FFA
VTVT icon

Farther Finance Advisors’s vTv Therapeutics VTVT Stock Holding History

Farther Finance Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Hold
283
– – ﹤0.01% 4381
2026
Q1 		$11.5K Buy
283
+4
+1% +$145 ﹤0.01% 4012
2025
Q4 		$11.2K Buy
+279
New +$7.77K ﹤0.01% 3836

Other funds holding VTVT

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's VTVT Position: Q2 2026 in Review

Farther Finance Advisors held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 283 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4381.

Farther Finance Advisors first reported a position in VTVT in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.5K in Q1 2026. 5 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Farther Finance Advisors held 283 shares of vTv Therapeutics worth $10.7K as of Q2 2026.
  • Farther Finance Advisors left its vTv Therapeutics share count unchanged in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4381 holding.
  • Farther Finance Advisors first reported a position in vTv Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's vTv Therapeutics position peaked at $11.5K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.